Plunkett Research Online: Kinnate Biopharma Inc

KINNATE BIOPHARMA INC (KNTE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Kinnate Biopharma Inc a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. The company's product candidate is KIN-2787, which is a Rapidly Accelerated Fibrosarcoma (RAF) inhibitor it is developin.....


KINNATE BIOPHARMA INC

Ticker: KNTE
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 858 299-4699
Fax:
Address: 11975 El Camino Real
San Diego, CA 92130 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Nima FarzanCEO/Director/President
Neha KrishnamohanCFO/Executive VP, Divisional
See More
Kinnate Biopharma Inc a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. The company's product candidate is KIN-2787, which is a Rapidly Accelerated Fibrosarcoma (RAF) inhibitor it is developin.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture